Do you want to read an article? Please log in or register.
Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy
Inflammatory Bowel Disease
Related content
COMMENTED
Inflammatory Bowel Disease
Intestinal Ultrasound as a Prognostic Tool in New-Onset Ulcerative Colitis - A Copenhagen IBD Cohort Study
★ 1
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Madsen GR, Wilkens R, Attauabi M, Ilvemark JFKF, Theede K, Bjerrum JT, Bendtsen F, Seidelin JB, Boysen T, Burisch J
doi: 10.1093/ecco-jcc/jjaf033
RECOMMENDED
Inflammatory Bowel Disease
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Inflamm Bowel Dis
Gisbert JP, Schreiber S, Siegel CA, Magro F, Jus A, Whichello C, Michaels-Igbokwe C, Heidenreich S, Oortwijn A, Vermeire S
doi: 10.1093/ibd/izae162
Gastrointestinal Cancer
The Impact of Advanced Medical Therapies on Time to Resection and Colorectal Cancer Outcomes in Ulcerative Colitis Patients Undergoing Colectomy
J Crohns Colitis
Visser E, Luberto A, Heuthorst L, Hompes R, Vermeire S, D'Haens GR, Bemelman WA, D'Hoore A, Bislenghi G, Buskens CJ
doi: 10.1093/ecco-jcc/jjaf015
Inflammatory Bowel Disease
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Inflamm Bowel Dis
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Gibble TH, Abreu MT, Lee SD, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Panaccione R, Dignass A
doi: 10.1093/ibd/izae253
Inflammatory Bowel Disease
Intestinal Ultrasound, Fecal Calprotectin, and Their Combination to Predict Endoscopic Mucosal Healing in Ulcerative Colitis: A Real-Life Cross-Sectional Study
Inflamm Bowel Dis
Yzet C, Meudjo E, Brazier F, Hautefeuille V, Moreau C, Robert C, Decrombecque C, Sarba R, Pichois R, Richard N, Meynier J, Fumery M
doi: 10.1093/ibd/izae145
Inflammatory Bowel Disease
Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis
Inflamm Bowel Dis
Karlovich N, McConnell R, Velayos F, Mahadevan U, Lewin S
doi: 10.1093/ibd/izae216
Inflammatory Bowel Disease
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
Lancet Gastroenterol Hepatol
Panaccione R, Vermeire S, Danese S, Higgins PDR, Lichtenstein GR, Nakase H, Glover S, Colombel JF, Eccleston J, Kujawski M, Remple V, Yao X, Geng Z, Palac H, Sharma D, Suravaram S, Schreiber S
doi: 10.1016/S2468-1253(25)00017-2
Inflammatory Bowel Disease
Biologic switch timing and risk of infection in patients with ulcerative colitis/Crohn's disease: a retrospective study
Clin Gastroenterol Hepatol
Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF
doi: 10.1016/j.cgh.2025.01.028
Inflammatory Bowel Disease
Effectiveness of Ustekinumab for patients with moderate to severe Ulcerative Colitis: A Multi-Center Real-World Canadian Study
Am J Gastroenterol
Solitano V, Narula N, Ma C, Nanayakkara A, Suarez KE, Zoughlami A, Guizzetti L, Bessissow T, Jairath V
doi: 10.14309/ajg.0000000000003212